Differential expression of human equilibrative nucleoside transporter 1 (hENT1) protein in the Reed-Sternberg cells of Hodgkin's disease (Q34155353)

31 July 2017

Differential expression of human equilibrative nucleoside transporter 1 (hENT1) protein in the Reed-Sternberg cells of Hodgkin's disease (English)

1 reference

31 July 2017

7

Stephen A Baldwin

1 reference

31 July 2017

Tony Reiman

1

1 reference

31 July 2017

Marilyn L Clarke

2

1 reference

31 July 2017

Laith Dabbagh

3

1 reference

31 July 2017

Michaela Vsianska

4

1 reference

31 July 2017

Robert W Coupland

5

1 reference

31 July 2017

Andrew R Belch

6

1 reference

31 July 2017

James D Young

8

1 reference

31 July 2017

Carol E Cass

9

1 reference

31 July 2017

John R Mackey

10

1 reference

31 July 2017

1 July 2002

1 reference

31 July 2017

1 reference

31 July 2017

43

1 reference

31 July 2017

7

1 reference

31 July 2017

1435-1440

1 reference

Nucleoside transporters: molecular biology and implications for therapeutic development

31 July 2017

1 reference

https://api.crossref.org/works/10.1080%2F1042819022386725

Nucleoside transport and its significance for anticancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819022386725

Cytosine arabinoside influx and nucleoside transport sites in acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819022386725

Es nucleoside transporter content of acute leukemia cells: role in cell sensitivity to cytarabine (araC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819022386725

Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819022386725

Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819022386725

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819022386725

Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819022386725

High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819022386725

Phase II trial of pentostatin in refractory lymphomas and cutaneous T-cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819022386725

Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819022386725

Transport of 2′-deoxycoformycin in human leukemie and lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819022386725

Expression of high levels of nitrobenzylthioinosine-sensitive nucleoside transport in cultured human choriocarcinoma (BeWo) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819022386725

Modulation of the equilibrative nucleoside transporter by inhibitors of DNA synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819022386725

A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819022386725

Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819022386725

Fatal pulmonary toxicity resulting from treatment with gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819022386725

Membranoproliferative glomerulonephritis following gemcitabine and vinorelbine chemotherapy for peritoneal mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819022386725

Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819022386725

Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819022386725

Detection of identical Hodgkin-Reed Sternberg cell specific immunoglobulin gene rearrangements in a patient with Hodgkin's disease of mixed cellularity subtype at primary diagnosis and in relapse two and a half years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819022386725

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819022386725

21 January 2018

Identifiers

DOI

10.1080/1042819022386725

1 reference

31 July 2017

1 reference